(19)
(11) EP 3 236 988 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
19.08.2020 Bulletin 2020/34

(45) Mention of the grant of the patent:
24.06.2020 Bulletin 2020/26

(21) Application number: 15817338.5

(22) Date of filing: 22.12.2015
(51) International Patent Classification (IPC): 
A61K 38/16(2006.01)
 A61P 31/04(2006.01)
(86) International application number:
PCT/EP2015/080924
(87) International publication number:
WO 2016/102536 (30.06.2016 Gazette 2016/26)

(54)

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL SUPERINFECTIONS POST-INFLUENZA

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON BAKTERIELLEN SUPERINFEKTIONEN NACH INFLUENZA

COMPOSITIONS PHARMACEUTIQUES POUR LE TRAITEMENT DE SUPERINFECTIONS BACTÉRIENNES POST-GRIPPALES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 23.12.2014 EP 14307154

(43) Date of publication of application:
01.11.2017 Bulletin 2017/44

(73) Proprietors:
  • INSERM (Institut National de la Santé et de la Recherche Médicale)
    75013 Paris (FR)
  • Centre National de la Recherche Scientifique (CNRS)
    75016 Paris (FR)
  • Université de Lille
    59800 Lille (FR)
  • Institut Pasteur de Lille
    59000 Lille (FR)

(72) Inventors:
  • SIRARD, Jean-Claude
    59019 Lille Cedex (FR)
  • CARNOY, Christophe
    59019 Lille Cedex (FR)
  • TROTTEIN, François
    59019 Lille Cedex (FR)
  • PORTE, Rémi
    59019 Lille Cedex (FR)

(74) Representative: Inserm Transfert 
7, rue Watt
75013 Paris
75013 Paris (FR)


(56) References cited: : 
WO-A1-2009/156405
WO-A1-2014/053481
 WO-A1-2011/161491
WO-A1-2014/053482
   
  • MUÑOZ NATALIA ET AL: "Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 78, no. 10, 1 October 2010 (2010-10-01), pages 4226-4233, XP009143515, ISSN: 0019-9567, DOI: 10.1128/IAI.00224-10 [retrieved on 2010-07-19]
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).